[Pharmacokinetics and pharmacodynamics of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) in the dog]

Pharmazie. 1985 Dec;40(12):869-70.
[Article in German]

Abstract

The antiarrhythmic action of GS 015 was studied in proportion to its plasma concentrations ascertained in parallel, making use of the model of the two-step coronary ligature in the conscious dog. Blood levels of 1.0 microgram/ml (2 mg/kg i.v.) or of 0.8 microgram/ml (5 mg/kg orally) brought about a complete suppression of ectopic arrhythmias. The limit concentration for this effect is about 0.5 microgram/ml.

Publication types

  • English Abstract

MeSH terms

  • Animals
  • Anti-Arrhythmia Agents / metabolism*
  • Anti-Arrhythmia Agents / pharmacology
  • Dibenzazepines / metabolism*
  • Dibenzazepines / pharmacology
  • Dogs
  • Kinetics
  • Myocardial Contraction / drug effects
  • Myocardium / metabolism
  • Time Factors

Substances

  • Anti-Arrhythmia Agents
  • Dibenzazepines
  • tiracizine